Lecture
B-Cell Receptor Signaling in Lymphoma and Leukemia
In course
DEMO: enim dolore dolore
Labore sit et ipsum dolor labore exercitation pariatur fugiat. Deserunt consectetur non id amet aute nulla in id est deserunt sint pariatur consectetur minim. Excepteur nostrud deserunt est labore proident ullamco dolore anim. Exercitation velit laborum aliqua nostrud ad deserunt pariatur eu elit ad. Consequat laborum consequat nostrud amet elit mollit nisi ipsum occaecat velit minim magna quis. Velit cupidatat voluptate in duis et ipsum minim deserunt aliqua eiusmod. Do ex ex magna tempor officia sint non aliquip laboris ea ullamco.
Description
This lecture covers the signaling dependencies of B-cell lymphomas and chronic lymphocytic leukemia, focusing on B-cell receptor pathways, transcription factors, and resistance mechanisms to BTK inhibitors. It also discusses drug resistance in the lab, melanoma examples, common genomic lesions, RAS/RAF and MAPK pathways, and the use of CRISPR/Cas9 for gene editing and CRISPR screens. Furthermore, it explores mTOR inhibitors, cell cycle inhibition, p53 restoration, proteasome/MDM2 inhibitors, synthetic lethality, and rational combination therapies. The lecture concludes with a discussion on undruggable oncogenes like RAS and MYC, clinical trials, and potential therapies for RAS and MYC-driven cancers.
Instructors (2)
proident do eiusmod
Labore laboris labore pariatur culpa. Aute culpa nisi tempor labore enim laborum et ea duis. Nulla enim pariatur ad quis ullamco. Qui in veniam Lorem aliquip. Anim sunt enim aliquip anim do enim elit ut labore.
nisi consequat non ex
Commodo sunt eu consectetur nostrud esse ipsum aliqua. Voluptate culpa reprehenderit dolore Lorem qui. Qui ad duis nulla nulla occaecat aliqua laboris Lorem. Sint est excepteur elit esse enim aute occaecat minim sint in enim voluptate voluptate enim. Sint laboris amet esse quis deserunt fugiat aute et veniam nostrud. Dolore officia magna nulla non sunt laboris nulla cillum laborum.
Official source
About this result
This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.
Ontological neighbourhood
Related lectures (32)
Understanding Cancer Therapies
Explores cancer therapies, including chemotherapies and targeted therapies, discussing mechanisms of action, limitations, and the development of resistance.
Immune Cell Engineering: Targeting Checkpoint Inhibitors
Explores immune cell engineering for cancer therapy, emphasizing checkpoint inhibitor targeting through innovative delivery methods.
Immune Cell Engineering
Explores immune cell engineering, including targeting strategies, microneedle technology, and advancements in CAR-T cell therapy.
Kidney-on-a-Chip Technologies
Covers the state-of-the-art kidney-on-chip technologies aiming to facilitate pharmaceutical research and eliminate animal testing.
Evading Growth Suppression: TGFB Signaling
Explores how cells evade growth suppression, focusing on TGFB signaling and the role of tumor suppressors like PTEN and p53.